Date | Time | Source | Headline | Symbol | Company |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:MKS | Marks And Spencer Group Plc |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:CRDA | Croda International Plc |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:INCH | Inchcape Plc |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:TKO | Taseko Mines Limited |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:CCH | Coca-cola Hbc Ag |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:CRDA | Croda International Plc |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:CCH | Coca-cola Hbc Ag |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:ALPH | Alpha Group International Plc |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:W7L | Warpaint London Plc |
06/01/2024 | 8:30AM | PR Newswire (Canada) | Message from the Governor General on National Indigenous History Month | | |
06/01/2024 | 8:30AM | PR Newswire (US) | Xtalks Announces its Life Science Webinar Calendar for June 2024 | | |
06/01/2024 | 8:30AM | PR Newswire (Canada) | Message de la gouverneure générale à l'occasion du Mois national de l'histoire autochtone | | |
06/01/2024 | 8:15AM | GlobeNewswire Inc. | Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting | NASDAQ:YMAB | Y mAbs Therapeutics Inc |
06/01/2024 | 8:10AM | Business Wire | Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting | NYSE:NUVB | Panacea Acquisition Corp |
06/01/2024 | 8:05AM | GlobeNewswire Inc. | Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting | NASDAQ:YMAB | Y mAbs Therapeutics Inc |
06/01/2024 | 8:05AM | PR Newswire (US) | Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 | NASDAQ:JAZZ | Jazz Pharmaceuticals PLC |
06/01/2024 | 8:01AM | Alliance News | EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech | LSE:TGR | Tirupati Graphite Plc |
06/01/2024 | 8:01AM | Alliance News | EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech | LSE:TPX | Tpximpact Holdings Plc |
06/01/2024 | 8:01AM | Alliance News | EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech | LSE:PIER | Brighton Pier Group Plc (the) |
06/01/2024 | 8:01AM | Alliance News | EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech | LSE:LPA | Lpa Group Plc |
06/01/2024 | 8:01AM | Alliance News | EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech | LSE:PINE | Pinewood Technologies Group Plc |
06/01/2024 | 8:01AM | Alliance News | EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech | LSE:PYC | Physiomics Plc |
06/01/2024 | 8:01AM | Alliance News | EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech | LSE:TAVI | Tavistock Investments Plc |
06/01/2024 | 8:01AM | Alliance News | EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech | LSE:RTOP | Regtech Open Project Plc |
06/01/2024 | 8:01AM | Alliance News | EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech | LSE:RTOP | Regtech Open Project Plc |
06/01/2024 | 8:00AM | Business Wire | Massive Bio to Unveil Drug Utilization Optimizer (DUO) at ASCO Annual Meeting 2024 | | |
06/01/2024 | 8:00AM | GlobeNewswire Inc. | Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024 | NASDAQ:MOLN | Molecular Partners AG |
06/01/2024 | 8:00AM | GlobeNewswire Inc. | CryptoHeap Targets Top Position in Crypto Staking Industry Before Bull Run Concludes | | |
06/01/2024 | 8:00AM | Business Wire | Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) | NYSE:PFE | Pfizer Inc |
06/01/2024 | 8:00AM | Business Wire | KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer | NYSE:BMY | Bristol Myers Squibb Co |